<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02941120</url>
  </required_header>
  <id_info>
    <org_study_id>AAG-O-H-1521</org_study_id>
    <nct_id>NCT02941120</nct_id>
  </id_info>
  <brief_title>Non-interventional Study With NOVOCART® Inject in the Reconstruction of the Knee Cartilage Defects</brief_title>
  <acronym>RENOVO</acronym>
  <official_title>Retrospective Observational Study for Reconstruction of Localized, Full-thickness Cartilage Defects in the Knee Joint With In-situ Polymerizable and Chondrocyte Populated Biomaterial (NOVOCART® Inject)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tetec AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aesculap AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Winicker Norimed GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Tetec AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in
      patients with full-thickness cartilage defects in the knee joint.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Retrospective and multicenter non-interventional study to evaluate safety and efficacy of
      NOVOCART® Inject in patients with localized full-thickness cartilage defects in the knee
      joint.

      Safety: Measuring the number of adverse drug reactions/serious adverse drug reactions since
      treatment and up to the present time.

      Efficacy: Evaluate symptoms and functional status at the present time using IKDC 2000
      (International Knee Documentation Committee) and KOOS (Knee injury osteoarthritis outcome
      score).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Actual">May 2019</completion_date>
  <primary_completion_date type="Actual">May 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of adverse drug reaction/serious adverse drug reaction</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Number of adverse drug reaction/serious adverse drug reaction as a measurement of safety</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Outcome of IKDC 2000</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Outcome of the IKDC 2000 as measurements of symptoms and function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Outcome of KOOS</measure>
    <time_frame>Up to 24 months</time_frame>
    <description>Outcome of KOOS as measurements of symptoms and function</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">245</enrollment>
  <condition>Cartilage Disease</condition>
  <arm_group>
    <arm_group_label>NOVOCART® Inject patients</arm_group_label>
    <description>Patients who where treated with NOVOCART® Inject autologous chondrocyte implantation in the knee joint.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Orthopaedic clinics
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male and female patients

          -  juvenile patients with closed epiphysial plate

          -  insulated full-thickness cartilage damage of the knee Joint, ICRS (International
             Cartilage Repair Society) grade 3-4

          -  defect size ≥ 2.5 and ≤ 10 cm2

          -  intact or reconstructed bony subchondral plate

          -  in the case of deep bony substance defects, additional bony reconstruction is needed

        Exclusion Criteria:

          -  radiographic signs of osteoarthritis of Kellgren and Lawrence &gt; 2

          -  joint stiffness

          -  arthrofibrosis

          -  malalignment in the knee (valgus- or varus deformity) &gt; 3° (correction contemporary to
             the ACT)

          -  insufficient reconstructed ligaments (correction contemporary to the ACT)

          -  defective position patella (correction contemporary to the ACT)

          -  sled prosthesis implants or carbon pin

          -  inflammatory joint diseases (f.e. rheumatoid arthritis)

          -  corresponding cartilage defects (&quot;kissing lesions&quot;)

          -  more than two independent cartilage defects in one knee

          -  primary cartilage reconstructive treatment in children and juvenile with open
             epiphysial plate

          -  diffuse chondromalacia

          -  congenital or gained deformity of patella
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hochtaunus-Kliniken gGmbH Krankenhaus Bad Homburg</name>
      <address>
        <city>Bad Homburg</city>
        <zip>61348</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gelenk-Klinik Gundelfingen</name>
      <address>
        <city>Gundelfingen</city>
        <zip>79194</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopädische Praxisklinik im Zentrum</name>
      <address>
        <city>Kelkheim</city>
        <zip>65779</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopädische Klinik Markgröningen gGmbH</name>
      <address>
        <city>Markgröningen</city>
        <zip>71706</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. med. Michael Moraldo, Dr. med. Sebastian Lauber</name>
      <address>
        <city>Münster</city>
        <zip>48165</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nordwest-Krankenhaus Sanderbusch gGmbH</name>
      <address>
        <city>Sande</city>
        <zip>26452</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Muldentalkliniken GmbH Krankenhaus Wurzen</name>
      <address>
        <city>Wurzen</city>
        <zip>04808</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>October 18, 2016</study_first_submitted>
  <study_first_submitted_qc>October 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2016</study_first_posted>
  <last_update_submitted>December 2, 2019</last_update_submitted>
  <last_update_submitted_qc>December 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cartilage defect</keyword>
  <keyword>Knee</keyword>
  <keyword>ACT (Autologous chondrocyte implantation)</keyword>
  <keyword>NOVOCART® Inject</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cartilage Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

